RecruitingNot ApplicableNCT07292272

Halt Aging in Survivors of Blood Cancers

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study


Sponsor

University of Nebraska

Enrollment

180 participants

Start Date

Apr 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Behavioral Coaching Intervention and a behavioral approach called Virtual Exercise Platform for people with hematological malignancy, leukemia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBehavioral Coaching Intervention

Intervention arm incorporating virtually supervised moderate-intensity aerobic exercise and behavioral intervention/coaching to improve adherence

BEHAVIORALVirtual Exercise Platform

Access to a virtual exercise platform that provides exercise classes and educational sessions for older survivors of blood cancer


Locations(1)

University of Nebraska Medical Center

Omaha, Nebraska, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07292272


Related Trials